Protein C deficiency

Haemophilia

Volumn 14, Issue 6, 2008, Pages 1214-1221

  Goldenberg, N A ^a,b   Manco johnson, Marilyn J ^a,c  

^a Nutrition Obesity Research Center at the University of Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Mountain States Regional Hemophilia and Thrombosis Center   (United States)

Author keywords

Disseminated intravascular coagulation; Neonatal thrombosis; Protein C; Purpura fulminans; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; DROTRECOGIN; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEXEL; UNCLASSIFIED DRUG; WARFARIN;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG HALF LIFE; FULMINATING PURPURA; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTICOAGULANTS; BLINDNESS; BLOOD COAGULATION; CHILD; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HETEROZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MUTATION; PHENOTYPE; PROTEIN C; PROTEIN C DEFICIENCY; PURPURA FULMINANS; RECOMBINANT PROTEINS; SEPSIS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 56049100230     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01838.x     Document Type: Article

References (36)

1. Stenflo J. A new vitamin K-dependent protein: Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-63.
2. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-3.
3. Seligsohn U, Berger A, Abend M et al. Homozygous protein C deficiencty manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559-62.
4. Estelles A, Garcia-Plaza I, Dasi A et al. Severe inherited "homozygous"protein C deficiency in a newborn infant. Thromb Haemost 1984; 52: 53-6.
5. Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR. Severe homozygous protein C deficiency. J Pediatr 1984; 105: 409-13.
6. Dahlbäck B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 1-43.
7. Gomez K, Laffan MA. Hunting for the mutation in inherited thrombophilia. Blood Coagul Fibrinolysis 2004; 15: 125-7.
8. Tait RC, Walker ID, Reitsma PH et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93.
9. Miletich J, Sherman L, Broze G Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-6.
10. Henkens CM, van der Meer J, Hellege JL, van der Schaaf W, Bom VJ, Halie MR. The clinical expression of hereditary protein C and protein S deficiency: A relation to clinical thrombotic risk factors and to levels of protein C and protein S? Blood Coagul Fibrinolysis 1993; 4: 555-62.
11. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Willmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: A prospective cohort study. Thromb Haemost 1994; 71: 441-5.
12. Allaart CR, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-8.
13. Bertina RM. Protein C deficiency and venous thrombosis: The search for the second genetic defect. Thromb Haemost 2000; 83: 360-1.
14. Reitsma PH, Bernardi F, Doig RG et al. Protein C deficiency: A database of mutations, 1995 update. On behalf of Subcommittee on plasma coagulation inhibitors of the SSC of the ISTH. Thromb Haemost 1995; 73: 876-9.
15. Alhenc-Gelas M, Gandrille S, Aubry M-L, Aiach M. Thirty-three novel mutations in the protein C gene. Thromb Haemost 2000; 83: 86-92.
16. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109: 3161-72.
17. Dalbäck B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: Novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol 2005; 25: 1311-20.
18. Esmon CT. The protein C pathway. Chest 2003; 124: 26-32.
19. Esmon C. The protein C pathway. Crit Care Med 2000; 28: S44-8.
20. Cobas MM, Langenfeld H, Rossaint R, Sablotzki A. PROWESS, ENHANCE, and ADDRESS: Clinical implications for the treatment with drotrecogin alfa (activated). Anaesthetist 2006; 55 (Suppl. 1): 16-23.
21. PetäjäJ, Manco-Johnson MJ. Protein C pathway in infants and children. Semin Thromb Hemost 2003; 29: 349-61.
22. Tcheng WY, Dovat S, Gurel Z, Donkin J, Wong W-Y. Severe congenital protein c deficiency: Description of a new mutation and prophylactic protein C therapy and in vivo pharmacokinetics. J Pediatr Hematol Oncol 2008; 30: 166-71.
23. Manco-Johnson MJ, Abshire TC, Jacobson LJ, Marlar RA. Severe neonatal protein C deficiency: Prevalence and thrombotic risk. J Pediatr 1991; 119: 793-8.
24. Marlar RA, Montgomery RR, Broekmans AW. Diagnosis and treatment of homozygous protein C deficiency. Report of the working party on homozygous protein C deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis. J Pediatr 1989; 114: 528-34.
25. Zimbelman J, Lefkowitz J, Schaeffer C et al. Unusual complication of warfarin therapy: Skin necrosis and priapism. J Pediatr 2000; 137: 266-8.
26. Kohler J, Kasper J, Witt I, von Reutern GM. Ischemic stroke due to protein C deficiency. Stroke 1990; 21: 1077-80.
27. Yates P, Cumber PM, Sanderson S, Harrison BJ. Mesenteric venous thrombosis due to protein C deficiency. Clin Lab Haematol 1991; 13: 137-9.
28. Pabinger I, Grafenhofer H. Thrombosis during pregnancy: Risk factors, diagnosis and treatment. Pathophysiol Haemost Thromb 2002; 32: 322-4.
29. Mackie I, Cooper P, Kitchen S. Quality assurance issues and interpretation of assays. Semin Hematol 2007; 44: 114-25.
30. Dreyfus M, Masterson M, David M et al. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost 1995; 21: 371-81.
31. [No authors Eisted.] Human protein C: New preparations: effective replacement therapy for some clotting disorders. Prescrire Int 2003; 12: 11-3.
32. Hartman KR, Manco-Johnson M, Rawlings JS, Bower DJ, Marlar RA. Homozygous protein C deficiency: Early treatment with warfarin. Am J Pediatr Hematol Oncol 1989; 11: 395-401.
33. Monagle P, Andrew M, Halton J et al. Homozygous protein C deficiency: description of a new mutation and successful treatment with low molecular weight heparin. Thromb Haemost 1998; 79: 756-61.
34. Dreyfus M, Magny JF, Bridey F et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991; 325: 1565-8.
35. Manco-Johnson MJ, Knapp-Clevenger R. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency. J Pediatr Hematol Oncol 2004; 26: 25-7.
36. Nadel S, Goldstein B, Williams MD et al. Drotrecogin alfa (activated) in children with severe sepsis: A multicentre phase III randomised controlled trial. Lancet 2007; 369: 836-43.